Vitamin K Bone Density Randomized Trial: What the Evidence Says

Quick Answer

Vitamin K Bone Density Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Bone health is a major concern for postmenopausal women, as estrogen deficiency after menopause accelerates bone resorption and suppresses bone formation, leading to reduced bone mineral density (BMD) and an increased risk of fractures. [Jung Susie (2026); evidence level 2]
• Among the various risk factors for osteoporosis, modifiable lifestyle factors-particularly insufficient calcium and vitamin D intake, as well as inadequate physical activity-are of special importance, alongside other established factors such as advanced age and low body mass index (BMI). [Jung Susie (2026); evidence level 2]
• To the Editor, Health Science Reports My colleagues and I read with great interest the cross-sectional study by Maharjan and colleagues, titled "Metabolic Dysfunction Associated Steatotic Liver Disease and Bone Turnover Markers in Postmenopausal Women: A Cross-Sectional Study in Central Nepal," published in. [Wen Xiao (2026); evidence level 4]
• However, as your study implicitly demonstrates, the direct evidence chain for routine vitamin D supplementation in preventing osteoporosis in community-dwelling adults, particularly when deficiency is not severe, is complex and not definitively linear. [Wen Xiao (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For vitamin K bone density randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Jung Susie (2026). Effects of Eggshell Calcium- and Vitamin D-Fortified HMR Combined with Aerobic Exercise on Bone Mineral Density in Postmenopausal Women: A Pilot Randomized Controlled Trial. DOI: 10.3390/nu18040605. PMCID: PMC12942995. PMID: 41754122. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12942995/
• Wen Xiao (2026). MASLD and Bone Markers in Postmenopause: Highlighting the Critical Gap of Vitamin D Status and the Need for Targeted Supplementation Trials. DOI: 10.1002/hsr2.72554. PMCID: PMC13239950. PMID: 42254306. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This is an open access.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13239950/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.